text:
JNJ : Analysis & Opinions
Hedge Funds Love These 3 Pharma StocksApril 14, 2014In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks. For 2 ...
Pharma & Biotech Stock Outlook - March 2014 - Industry OutlookMarch 25, 2014Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Bull of the Day: Quintiles (Q) - Bull of the DayMarch 5, 2014Bull of the Day: Quintiles (Q) - Bull of the Day
How To Smooth-Out Your Ride In The Stock MarketMarch 3, 2014Volatility is back. For investors, this nasty problem of gyrating markets can be a real hindrance to your portfolio's total ...
Earnings Front & Center - Ahead of Wall StreetJanuary 21, 2014The overall tone of the reports this morning is positive, though some guidance is a bit on the soft side.
Pharma & Biotech Stock Outlook - Dec 2013 - Industry OutlookDecember 3, 2013Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
Bull of the Day: Pharmacyclics (PCYC) - Bull of the DayOctober 31, 2013Bull of the Day: Pharmacyclics (PCYC) - Bull of the Day
Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...September 14, 2013Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
14 Companies That Have Raised Their Dividends For 50 Years Or ...September 10, 2013Imagine if you had bought these stocks 20 years ago.If you had, then right now you'd be earning dividend yields of... ...
MedTech Industry Stock Update - Sept 2013 - Industry OutlookSeptember 10, 2013MedTech Industry Stock Update - Sept 2013 - Industry Outlook
The Street Has Caught CovidienAugust 1, 2013Covidien's quality isn't the issue, but Wall Street's love for it may be.
After A Sharp Pullback, Is Allergan Pretty Enough?July 31, 2013Down on fears about generics and the pipeline, the Street may be underestimating Allergan
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry OutlookJuly 30, 2013Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
Roche Delivering Leverage, But Still Needs DiversificationJuly 29, 2013If Roche can balance out its sales mix, the long-term value could be quite compelling at present prices.
Celgene Only Getting Started, But The Street's Already Looking ...July 26, 2013Biotech valuations are into the nose-bleed zone, but Celgene continues to execute very well.
Stryker Seems Back On TrackJuly 19, 2013Stryker's revenue growth looks fine, but there are still pressures in the end markets.
Intuitive Surgical Burning Up On Re-EntryJuly 19, 2013Intuitive Surgical has to reset expectations, and that's leading to a painful reassessment of the fair value.
Where Do The Bears Go Next With St. Jude Medical?July 18, 2013St. Jude continues to defy bearish expectations of major share loss, but the shares aren't exactly cheap today.
Positive Start to Q2 Earnings Season - Ahead of Wall StreetJuly 16, 2013Though heavily Finance weighted at this stage, the early reports are
Stock Market News for July 15, 2013 - Market NewsJuly 15, 2013Benchmarks posted marginal gains on Friday following better-than-expected results of few banking companies.
Earnings Expectations for the Week of July 15July 14, 2013The earnings season ramps up this week, providing plenty of perspective on how the financial and technology sectors fared ...
Q2 Earnings season get into high gear - Earnings PreviewJuly 12, 2013Q2 Earnings season get into high gear - Earnings Preview
Prestige Brands Gets Upgraded: Should You Be Buying?July 11, 2013At least two investment firms upgraded Prestige Brands' (NYSE:PBH) stock July 9 on news it had acquired a small Australian ...
Hospira Touches 52-week High - Analyst BlogJuly 10, 2013Shares of Hospira soared to a 52-week high of $39.48 on Jul 9
Intuitive Surgical's Miss Looks Systemic And Company-SpecificJuly 9, 2013A surprising drop in U.S. system placements is going to put Intuitive Surgical in the penalty box.
Bayer Announces Positive Phase I Data - Analyst BlogJuly 8, 2013Bayer announced positive results from a phase I study on PCCs.
Profiting With Straddles This Earnings Season - Know Your OptionsJuly 2, 2013Profiting With Straddles This Earnings Season - Know Your Options
Yet Another Setback for Bayer/JNJ's Xarelto - Analyst BlogJuly 2, 2013Bayer and Johnson & Johnson received a CRL from the FDA for Xarelto.
Good News for Hospira, Shares up - Analyst BlogJuly 2, 2013The EMA's CHMP recommended the approval of Hospira's biosimilar version of Remicade.
CHMP Positive on Dendreon's Provenge - Analyst BlogJuly 1, 2013The CHMP provided a positive opinion on Dendreon's marketing application for Provenge.
Stock Market News for July 1, 2013 - Market NewsJuly 1, 2013Benchmarks ended a three day gaining streak on Friday as fears of the Federal Reserve scaling back the bond buying program ...
Stock Market News for June 27, 2013 - Market NewsJune 27, 2013Weaker-than-expected GDP numbers eased investor concerns that the Federal Reserve would decrease monetary stimulus in the ...
Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...June 26, 2013Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
Data from Bayer/JNJ's Xarelto Study - Analyst BlogJune 25, 2013Bayer's announced that it will present data from a Xarelto clinical program.
Rising 10-Year Yields Could Crush Popular Dividend ETFsJune 21, 2013Seduced by backward-looking dividend increase streaks, investors have fallen in love with dividend ETFs such as the Vanguard ...
Nektar's Pain Drug Impresses - Analyst BlogJune 20, 2013Nektar announced encouraging top-line results from its HAL study on NKTR-181.
Data on PCYC's ibrutinib - Analyst BlogJune 20, 2013Pharmacyclics announced that data on ibrutinib was published in the NEJM.
Priority Review for Gilead Drug - Analyst BlogJune 10, 2013The NDA on Gilead's sofosbuvir will be reviewed on a priority basis by the FDA.
Little Left To Dendreon But The Hope TradeMay 10, 2013Dendreon looks increasingly irrelevant as the medical community moves on from Provenge.
Recent Financials May Not Be Entirely Fair To HologicMay 8, 2013Macro pressures are outweighing solid internal progress at Hologic.
In A Growth-Starved Sector, Becton Dickinson RulesMay 3, 2013Becton Dickinson is a great business, but investors seem to be too willing to overpay for today's relatively stronger growth. ...
It Gets A Little Harder From Here For CovidienApril 29, 2013Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
Is Controversy About Robot-Assisted Surgery Showing In Intuitive ...April 19, 2013Uncertainty about procedure growth may be opening a window in these often-expensive shares
Broad Weakness Makes It Harder To Like St. Jude TodayApril 18, 2013Although I do believe the long-term expectations for St. Jude are increasingly beatable, this could be a frustrating stock ...
Pharma Is Doing All The Pulling For Johnson & JohnsonApril 17, 2013Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
'Great Rotation': Fact or Fiction - Analyst BlogFebruary 11, 2013Domestic stock funds garnered a whopping $21 billion in the initial four weeks of 2013, according to Lipper. This was the ...
Pipeline Setback for Idenix - Analyst BlogFebruary 7, 2013Idenix Pharmaceuticals, Inc. (IDIX) recently announced that the company has decided to discontinue its clinical development ...
Elan Beats on Sales, Loses Tysabri - Analyst BlogFebruary 7, 2013Elan Corporation (ELN) reported earnings of 15 cents per share for the fourth quarter of 2012 compared to the year-ago loss ...
Bayer, J&J Collaborate with Portola - Analyst BlogFebruary 6, 2013Bayer's (BAYRY) Healthcare unit and Johnson & Johnson's (JNJ) Janssen Pharmaceuticals recently collaborated with Portola ...
LRY Unveils $55M Project - Analyst BlogFebruary 5, 2013Yesterday, Liberty Property Trust (LRY) - a hybrid real estate investment trust (REIT) - unveiled its plan to construct an ...
Stock Market News for January 30, 2013 - Market NewsJanuary 30, 2013Better-than-expected quarterly results once again guided the S&P 500 and the Dow Jones into the green on Tuesday. Strong ...
MedTech Industry Stock Outlook - Jan 2013 - Zacks Analyst InterviewsJanuary 29, 2013We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the worldwide ...
Stock Market News for January 23, 2013 - Market NewsJanuary 23, 2013Better-than-expected earnings from major companies lifted benchmarks into positive territory on Tuesday ahead of earnings ...
Stryker Follows Its Rivals With A Big Investment In ChinaJanuary 22, 2013Stryker's acquisition of Trauson is the right deal at the right time.
Market Awaiting Big Tech Earnings - Analyst BlogJanuary 22, 2013Stocks will likely take a breather today given the mixed earnings picture emerging from a busy reporting day. The market ...
Ahead of Wall Street - January 22, 2013 - Ahead of Wall StreetJanuary 22, 2013Tuesday, January 22, 2013 Stocks will likely take a breather today given the mixed earnings picture emerging from a busy ...
Pfizer's Quillivant Launched - Analyst BlogJanuary 17, 2013Pfizer Inc. (PFE) recently announced that it has launched its attention deficit hyperactivity disorder (ADHD) treatment, ...
Glaxo Seeks Albiglutide Approval - Analyst BlogJanuary 15, 2013GlaxoSmithKline (GSK) recently announced the submission of a marketing application to the US Food and Drug Administration ...
Digital Realty Expands in Australia - Analyst BlogJanuary 10, 2013In order to expand its Australian footprints, Digital Realty Trust Inc. (DLR) recently acquired an established data center ...
Alkermes Maintains Fiscal 2013 View - Analyst BlogJanuary 9, 2013Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to expect ...
Cooper Downgraded to Neutral - Analyst BlogDecember 26, 2012We downgrade our recommendation on The Cooper Companies (COO) to Neutral following its fiscal fourth quarter (ended October ...
Myriad Alleviates to Outperform - Analyst BlogDecember 21, 2012Following a strong first quarter result and an encouraging guidance, we upgrade our recommendation on Myriad Genetics (MYGN), ...
Encouraging News for Shire - Analyst BlogDecember 21, 2012Shire plc (SHPG) recently received some encouraging news from Europe regarding its attention deficit/hyperactivity disorder ...
NVO Progresses with Pipeline - Analyst BlogDecember 20, 2012Novo Nordisk (NVO) recently completed a phase IIIa study on IDegLira, which is a combination of Tresiba (insulin degludec) ...
Positive Data on Actelion Candidate - Analyst BlogDecember 19, 2012Actelion (ALIOF) recently announced positive results from a phase II study on its S1P1 modulator, ponesimod. Actelion is ...
Merck Ties Up with GE Healthcare - Analyst BlogDecember 19, 2012Merck (MRK) is collaborating with GE Healthcare for the use of an investigational positron emission tomography (PET) imaging ...
Glaxo's Anthrax Drug Gets FDA Nod - Analyst BlogDecember 18, 2012GlaxoSmithKline (GSK) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug ...
CHMP Negative on Isis' Kynamro - Analyst BlogDecember 17, 2012The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not recommend ...
J&J Files NDA for Combo Diabetes Drug - Analyst BlogDecember 14, 2012Janssen Research & Development, LLC, a part of the Johnson & Johnson (JNJ) family of companies, recently announced the submission ...
Label Expansion for JNJ's Zytiga - Analyst BlogDecember 12, 2012Johnson & Johnson's (JNJ) Janssen recently announced that the FDA has granted approval for the label expansion of the company's ...
Gilead Plans to Split Stock 2-for-1 - Analyst BlogDecember 11, 2012Recently, the board of directors at Gilead Sciences Inc. (GILD) authorized a two-for-one stock split. The action, which will ...
Myriad Teams Up with Sanofi - Analyst BlogDecember 11, 2012Myriad RBM, a wholly-owned subsidiary of molecular diagnostic company Myriad Genetics Inc. (MYGN), has recently collaborated ...
Merck's Alzheimer's Drug Progresses - Analyst BlogDecember 10, 2012Merck (MRK) recently moved its Alzheimer's disease candidate, MK-8931, into a phase II/III study (EPOCH). The study will ...
Pharma & Biotech Stock Outlook - Dec 2012 - Zacks Analyst InterviewsDecember 6, 2012The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent times. The ...
Smith & Nephew's Costly DealNovember 29, 2012Smith & Nephew is having to pay a pretty hefty price for this growth injection and this just isn't a sustainable long-term ...
Gilead Reports Positive HCV Data - Analyst BlogNovember 29, 2012Gilead Sciences (GILD) recently presented encouraging top-line data from a phase III study (Positron) which evaluated its ...
Abbott's Humira's Label Expanded - Analyst BlogNovember 28, 2012Abbott Labs (ABT) recently received approval for yet another indication of Humira (adalimumab). The European Commission approved ...
Dividend Stocks Lose Luster? - Analyst BlogNovember 26, 2012The average dividend yield on S&P 500 stocks has approximately halved to 2% over time. While significant inflows to these ...
Medtronic's Growth Looks Good, But Can It Last?November 22, 2012Medtronic may not be a super grower anymore, but it's doing better than the Street seems to acknowledge
Incyte Progresses on RA Candidate - Analyst BlogNovember 20, 2012Incyte Corporation (INCY) and Eli Lilly and Company (LLY) recently announced positive results from an ongoing 24-week phase ...
Alkermes Reverts to Neutral - Analyst BlogNovember 16, 2012We are reverting to a Neutral recommendation on Alkermes plc (ALKS) from Outperform as we believe that the stock is fairly ...
Still Neutral on DexCom - Analyst BlogNovember 15, 2012Following the third quarter earnings release, we are maintaining our long-term 'Neutral' recommendation on DexCom (DXCM), ...
Cooper Launches New Closure System - Analyst BlogNovember 7, 2012CooperSurgical, a part of The Cooper Companies (COO), a company focused on contact lens and women's health, recently revealed ...
Endo Health Solutions Needs Some Solutions Of Its OwnNovember 7, 2012Can Endo reestablish itself as a quality healthcare name?
Disappointing Quarter from Vertex - Analyst BlogNovember 5, 2012Vertex Pharmaceuticals Inc. (VRTX) posted break-even (including stock-based compensation expense) results in the third quarter ...
Is "Less Bad" As Good As It Gets For Dendreon?November 5, 2012Dendreon has made progress with its expenses, but the sluggish revenue growth is still the major problem.
DexCom Continues to Incur Loss - Analyst BlogNovember 5, 2012DexCom (DXCM), a player in the glucose monitoring market, reported third quarter 2012 loss per share of 25 cents, higher ...
Merck Beats on EPS, Narrows View - Analyst BlogOctober 26, 2012Merck & Co. (MRK) reported third quarter 2012 earnings per share (excluding special items) of 95 cents, a couple of cents ...
Loss at Elan Wider than Expected - Analyst BlogOctober 25, 2012Elan Corporation's (ELN) loss of 5 cents per share (excluding special items) for the second quarter of 2012 was wider than ...
Beat and Raise Quarter for Amgen - Analyst BlogOctober 24, 2012Amgen (AMGN) continued its strong performance in 2012 with third quarter earnings coming in at $1.66 per share, 23 cents ...
GE's Results Reflect An Industrial Slowdown, But Valuation Isn't ...October 23, 2012GE may have disappointed, but the company and its stock are both in good shape today.
These Companies Have Raised Their Dividends for 50 Consecutive ...October 18, 2012Imagine if you had bought these stocks 20 years ago. If you had, then right now you'd be earning dividend yields of... 27%... ...
Taking Stock of the Q3 Earnings season - Analyst BlogOctober 17, 2012Less than impressive earnings results from Intel (INTC), IBM (IBM), and CSX Corp. (CSX) after the close cap a busy earnings ...
Abbott Reports Encouraging HCV Data - Analyst BlogOctober 16, 2012Abbott Laboratories (ABT) recently announced promising data from the phase IIb Aviator trial evaluating the combination of ...
Merck's MK-3102 Encourages - Analyst BlogOctober 11, 2012Merck (MRK) recently presented encouraging phase IIb data on its type II diabetes candidate, MK-3102, at the annual meeting ...
Encouraging Data on J&J Candidate - Analyst BlogOctober 10, 2012Janssen Research & Development, LLC, a part of the Johnson & Johnson (JNJ) family of companies, recently presented encouraging ...
New Indication for Abbott's Humira - Analyst BlogOctober 4, 2012Abbott Labs (ABT) recently announced that it has received approval for an additional indication of Humira (adalimumab) from ...
Novartis Progresses with AIN457 - Analyst BlogOctober 1, 2012Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced phase II data on its pipeline candidate, AIN457 ...
3 ETFs In Focus As Election NearsSeptember 27, 2012ETFs have earned the respect of countless investors as viable financial instruments well suited as core building blocs for ...
Glaxo Back on a Neutral Path - Analyst BlogSeptember 25, 2012GlaxoSmithKline plc (GSK) performed disappointingly in the second quarter of 2012, missing the Zacks Consensus Estimate both ...
Bayer Seeks European Approval - Analyst BlogSeptember 21, 2012The HealthCare unit of Bayer (BAYRY) announced recently that it has filed an application seeking approval to market its low-dose ...
Myriad Remains Neutral - Analyst BlogSeptember 21, 2012We have reaffirmed our Neutral recommendation on Myriad Genetics (MYGN) with a target price of $29.00. The company reported ...
FDA Panel to Review Celgene Drug - Analyst BlogSeptember 20, 2012Celgene Corporation (CELG) recently announced that Oncologic Drugs Advisory Committee (ODAC) of the US Food and Drug Administration ...
Impax in Settlement Agreement - Analyst BlogSeptember 20, 2012Impax Laboratories, Inc. (IPXL) and Teva Pharmaceuticals USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical Industries ...
Bayer Upped to Outperform - Analyst BlogSeptember 19, 2012Encouraged by strong second quarter 2012 results, an upbeat guidance and a series of positive subsequent developments, we ...
Back to Neutral on Alkermes - Analyst BlogSeptember 18, 2012We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is fairly valued at current ...
Shire Aims to Expand Vyvanse Label - Analyst BlogSeptember 17, 2012Shire plc (SHPG) recently announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental ...
Cooper Companies: A Strong Buy - Analyst BlogSeptember 12, 2012Rising earnings estimates on the back of strong third quarter fiscal 2012 results helped Cooper Companies (COO) achieve a ...
Cooper Tops, Raises FY12 View - Analyst BlogSeptember 7, 2012The Cooper Companies (COO), a company focused on contact lens and women's health, reported third-quarter fiscal 2012 (ended ...
Elan Starts Phase II ELND005 Study - Analyst BlogSeptember 6, 2012Elan Corporation (ELN) recently initiated a phase II placebo-controlled, safety and efficacy study with oral ELND005. ELND ...
ScoliScore Could Be A Needle-Mover For TBIO - Analyst BlogAugust 29, 2012ScoliScore Could Be A Needle-Mover For TBIO ScoliScore Could Be A Needle-Mover For TBIO Yesterday (8/28/2012) Transgenomic ...
coliScore Could Be A Needle-Mover For TBIO - Analyst BlogAugust 29, 2012coliScore Could Be A Needle-Mover For TBIO Brian Marckx, CFA Yesterday (8/28/2012) Transgenomic (TBIO) announced an ...
DexCom Remains Neutral - Analyst BlogAugust 27, 2012We reiterate our Neutral recommendation on DexCom Inc. (DXCM). Its second-quarter 2012 loss per share of 21 cents exceeded ...
Hansen Medical Boosts IP Portfolio - Analyst BlogAugust 24, 2012Hansen Medical (HNSN), a global developer and manufacturer of intravascular robotics, recently announced the expansion of ...
FDA Extends PFE Drug Review Period - Analyst BlogAugust 22, 2012The US Food and Drug Administration (FDA) recently extended its review period for Pfizer's (PFE) rheumatoid arthritis (RA) ...
Pfizer Looks To Spin Off Animal Health UnitAugust 15, 2012Pfizer has filed plans to sell up to 20% of its animal-health unit in the first half of 2013 to focus on human pharmaceuticals. ...
Elan to Split into Two Companies - Analyst BlogAugust 14, 2012Elan Corporation (ELN) recently announced its decision to split into two separate publicly traded companies. The spin-off, ...
The Week Ahead In HealthcareAugust 13, 2012The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit, likely in part because Johnson & Johnson ...
The Week Ahead In HealthcareAugust 8, 2012The week ahead for healthcare stocks.
DexCom Misses on EPS, Losses Climb - Analyst BlogAugust 7, 2012DexCom (DXCM), a player in the glucose monitoring market, reported second-quarter 2012 loss per share of 21 cents, higher ...
Solid Quarter at ALKS, View Backed - Analyst BlogJuly 31, 2012Alkermes plc (ALKS) reported earnings of 28 cents per share (including depreciation and stock-based compensation expenses) ...
More Healthy Alternatives To ZimmerJuly 30, 2012Zimmer has turned to cost cutting to keep total profit growth moving positively forward, but doesn't appear to have any answers ...
Amgen Beats, Raises Guidance - Analyst BlogJuly 27, 2012Amgen (AMGN) continued its strong performance in 2012 with second quarter earnings coming in at $1.82 per share, 31 cents ...
Mixed 3Q for Covidien, Profit Drops - Analyst BlogJuly 26, 2012Covidien plc (COV), a large-cap medical technology company, reported its adjusted earnings per share (from continuing operations) ...
Pfizer, J&J Drug Fails in 1st Study - Analyst BlogJuly 24, 2012Pfizer, Inc. (PFE) recently announced highly-awaited top-line results on Alzheimer's disease candidate, bapineuzumab. Pfizer ...
4 Dividend ETFs With Higher Yields Than LQDJuly 24, 2012Once upon a time, the conventional wisdom was that investors should hold stocks as a source of long-term capital appreciation ...
Company News for July 18, 2012 - Corporate SummaryJuly 18, 2012" The Coca-Cola Company (NYSE:KO) reported second quarter earnings per share of $1.22, beating the Zacks Consensus Estimate ...
How to Hear What Bernanke Is Saying - Analyst BlogJuly 17, 2012The QE question will again be on many investors' minds today as Ben Bernanke testifies before the Senate Banking committee. ...
Ahead of Wall Street - July 17, 2012 - Ahead of Wall StreetJuly 17, 2012Tuesday, July 17, 2012 The QE question will again be on many investors' minds today as Ben Bernanke testifies before ...
The Week Ahead In HealthcareJuly 16, 2012Healthcare stocks continue to outperform this year. Here's what you can expect for the sector in the week ahead.
What Patent Cliff? Pharma ETFs Continue to Surge - ETF News And ...July 10, 2012For at least the past few years, investors in the health care segment have been focused in on big pharma and the segment's ...
Setback for Chelsea Therapeutics - Analyst BlogJuly 6, 2012Chelsea Therapeutics International, Ltd. (CHTP) recently suffered a setback when the US Food and Drug Administration (FDA), ...
GolinHarris Acquires Virgo Health - Analyst BlogJuly 6, 2012GolinHarris, a division of Interpublic Group (IPG) intends to acquire Virgo Heath, an independent UK-based Healthcare Communications ...
The Week Ahead In HealthcareJuly 6, 2012Early July offers another slow week in healthcare.
Gilead Seeks FDA OK for Cobicistat - Analyst BlogJuly 2, 2012Recently, Gilead Sciences, Inc. (GILD) announced that it has filed a marketing application seeking approval for its HIV candidate, ...
June's Best Dow StocksJune 30, 2012The Dow Jones Industrial Average closed June and the second quarter in stellar fashion with an astounding 278-point gain ...
Gilead Seeks FDA Approval - Analyst BlogJune 28, 2012Recently, Gilead Sciences, Inc. (GILD) announced that it has filed a marketing application seeking approval for its HIV candidate, ...
Health Care ETFs in Focus on Obamacare Supreme Court Decision ...June 27, 2012In what looks to be the biggest Supreme Court decision since Bush v. Gore, the highest court in the land will give its opinion ...
Bio-Reference Labs Taking Advantage Of Esoteric OpportunitiesJune 22, 2012The decision of whether to buy Bio-Reference really comes down to an investor's confidence in the growth prospects for the ...
EMA Validates Gilead's Drug - Analyst BlogJune 20, 2012Recently, Gilead Sciences, Inc. (GILD) announced that its marketing application seeking approval for its HIV candidate elvitegravir ...
Perrigo in Neutral Lane - Analyst BlogJune 14, 2012We have maintained our Neutral rating on Perrigo Company (PRGO) with a target price of $112.00. Our long-term recommendation ...
ETF Trading Report: Swiss, Health Care ETFs In Focus - ETF News ...June 13, 2012Stocks had trouble staying above water during Wednesday's session as Jamie Dimon's testimony and weak retail sales weighed ...
Covidien Promotes Zogenix's Product - Analyst BlogJune 8, 2012The pharmaceutical unit of Covidien plc (COV) and Zogenix Inc. (ZGNX) have recently agreed to co-endorse a prescription medicine ...
Cooper Misses, Tweaks Guidance - Analyst BlogJune 8, 2012The Cooper Companies (COO), a company focused on contact lens and women's health, reported second-quarter fiscal 2012 (ended ...
Abbott Presents Data on Humira - Analyst BlogJune 7, 2012Abbott Labs (ABT) recently presented phase III data on its blockbuster drug, Humira, from two studies. While ABILITY-2 is ...
The Trend In Rising Cancer IncidencesJune 5, 2012As the world continues to modernize and grow, global cancer incidences are expected to increase exponentially and pharmaceutical ...
Rockwood Has Its Risks, But Also Some Apparent ValueMay 31, 2012Rockwood has economic risks, but offers real growth opporunities in higher-value lithium and ceramics.
Company News for April 20, 2011 - Corporate SummaryMay 9, 2012• Johnson & Johnson (NYSE:JNJ) reported Q1 EPS of $1.35, ex-items, ahead of the Zacks Consensus Estimate of $1.25 per share. ...
Volcano Corp. Misses by a Penny - Analyst BlogMay 3, 2012Volcano Corp. Misses by a Penny - Analyst Blog
Don't Underestimate Dividends In A RecessionApril 30, 2012Today, businesses that provide the most basic human needs - food and medicine - are paying above-normal rates of return.
3 Undervalued Tech-Sector GemsApril 27, 2012Following are a trio of stocks that have yet to claw their way back to their perches before the global economic maelstrom ...
5 Easy Ways to Cash In on US DividendsApril 26, 2012If you're outside the US looking in, there are important pros and cons to adding exchange traded funds from America ...
The Perfect Rx for Your PortfolioApril 4, 2012These three big drug stocks offer attractive yields and relative safety heading into the more challenging summer months, ...
7 Great Names for Dividend YieldMarch 30, 2012Large, dividend-paying equities are good portfolio additions in this low-interest-rate environment, says asset manager Chip ...
Ruling Or Not, Healthcare Still WinsMarch 29, 2012The Affordable Care Act finally goes in front of the Supreme Court. However, the Justice's ruling may not matter. Healthcare ...
Dividends That Will Keep GrowingMarch 26, 2012The value that these companies have created over the years is mainly due to the dividends they pay out to investors.
5 Reasons to Love Dividend GrowthMarch 15, 2012What a smart strategy for DIY investors: It's idiot and inflation proof, it's money for nothing…and best ...
Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?March 6, 2012Several states have already slashed birth control subsidies. Learn how this will affect pharmaceutical stocks.
Medtronic In Recovery ModeFebruary 27, 2012Medtronic's valuation is very appealing given its leadership position in the medical device industry.
The 10 Must-Know Market Forces for 2012February 14, 2012For the first time since 2007, investors have multiple ways to succeed this year. Understanding how the lingering effects ...
Finding Quality and YieldFebruary 9, 2012The dividend yield theory helps Kelley Wright of Investment Quality Trends find value in the market. Here, he explains ...
Procter & Gamble Feels The PinchJanuary 31, 2012U.S sales growth combined with rising input costs helped put a lid on the company's quarter.
Health Care's Highest YieldsJanuary 30, 2012Some of the biggest and highest-yielding drug stocks are declining near attractive buy levels, giving income-oriented investors ...
Colgate-Palmolive Has Growth, But It'll Cost YaJanuary 30, 2012Colgate has great growth, but a valuation to match.
Stryker Leaning Away From KneesJanuary 26, 2012A fair amount of future growth is already baked into Stryker's valuation.
The Long-Term Play In Lab WorkJanuary 16, 2012As drugmakers beef up their pipelines in this world of rising costs, the contract research sector should profit.
The Hot ETF for 2012January 11, 2012Here's a look at the method behind the picking my annual Hot Hand, so even if the pick misfires, at least you can buy into ...
A Better ETF for Metals InvestorsJanuary 11, 2012The most common silver and gold ETFs may present risks unknown to most investors, says asset manager and analyst Mo Dawoud. ...
Bristol-Myers Pays Up To Patch A GapJanuary 9, 2012Bristol-Myers recently bought Inhibitex, a company leading the way in developing a treatment for Hepatitis C.
Don't Count Out Healthcare StocksJanuary 6, 2012The healthcare sector remains bogged down in a mire of regulation and dwindling spending.
Slow And Steady ETFs OutperformingJanuary 3, 2012Low volatility ETFs lead the way in 2011.
2011's Biggest Mergers and AcquisitionsDecember 30, 2011M&A activity rebounded in a big way in 2011. Here's a look back at the biggest mergers and acquisitions during the year.
2011 - Another Sick Year For Larger Med-TechDecember 29, 2011Larger healthcare companies are still getting sickly returns in the market.
How to Evaluate Global Dividend StocksDecember 22, 2011Dividend yield is the most important factor to use when evaluating investment opportunities, says London-based portfolio ...
Stryker Falling Back To EarthDecember 16, 2011Stryker Corp's stock offers the potential for above-average shareholder returns with modest downside risk.
Synovis Has To Bow Out To Get Some LoveDecember 15, 2011Synovis is undervalued no longer.
Uncertainty Still Means Discount For WellPointNovember 30, 2011Uncertainty still means discount for WellPoint.
Medtronic May Be A Heavyweight, But It Can Still Hit HardNovember 28, 2011Medtronic has gone from over-loved to under-loved, and value investors should take note.
Medtronic Stable In A Challenging MarketNovember 25, 2011Medtronic's stock is worth a close look.
Is Third Time The Charm For Gilead?November 22, 2011Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
Canadians, Look Before You Leap SouthNovember 22, 2011Before painting their portfolios red, white, and blue, Canadian income investors need to understand the drawbacks of playing ...
Covidien Delivers Once AgainNovember 21, 2011Covidien is overlooked and undervalued.
Medicis May Not Stay IndependentNovember 10, 2011Medicis is well-run, but arguably too risky to stay independent.
If CareFusion Can Execute, This Is A Major BargainNovember 9, 2011CareFusion has to make some improvements, but it could really reward investors.
Dendreon's Chinese Water TortureNovember 3, 2011Dendreon's Provenge continues to shape up as a major disappointment.
Merck's Penance Has Gone On Long EnoughOctober 31, 2011Merck won't grow fast, but it's quality is undervalued. It's time for investors to reevaluate it.
Zimmer Looking To Escape Its Value TrapOctober 31, 2011Zimmer continues to trade at a very reasonable forward P/E.
Big Dividends, Small RiskOctober 31, 2011Businesses that payout nice dividends can offer reasonable substitutes for some investors.
Boogeymen That Keep CEOs Awake At NightOctober 28, 2011Executives of these high-profile companies have no shortage of fears to keep them awake at night.
Abbott Has Benefited From Its DiversificationOctober 25, 2011Why is Abbott deciding to break apart?
St. Jude Still A Patient TradeOctober 24, 2011St. Jude's growth is lacking, today. However, it could be a winner for the patient investor.
Stryker Scraping ByOctober 24, 2011Stryker's growth is modest, but the stock potential is surprising.
Abbott Labs Joins The Separation MovementOctober 24, 2011Abbott is joining the separation movement that is sweeping across corporate America. The company plans to break into a medical ...
High Yielding EquitiesOctober 21, 2011Despite the market volatility, there are still some stocks and ETFs that pay above-average dividend yields.
5 Must-Know Stocks For TuesdayOctober 17, 2011Here are four companies that will be releasing their earnings on October 18.
Can AngioDynamics Get Hearts Racing?October 11, 2011With a new CEO, a strong balance sheet, and good technology, investors might want to check out AngioDynamics. The comopany ...
Is Jabil Quietly Loading Both Barrels?September 30, 2011Jabil's revenue is holding up better than its customers.
Berkshire Buys Shares And ControversySeptember 29, 2011Berkshire announced its intention to buy back shares, but what does that mean for investors?
Attractive Dividend Stocks To WatchSeptember 27, 2011Dividend yields, despite how insignificant they may seem, are a major component of equity returns as times goes on
Medtronic's Healthy Growth OutlookAugust 29, 2011Medtronic's stock deserves a close look.
AAA-Rated Stocks Lead S&P 500August 25, 2011These four blue chips are the only S&P 500 companies with AAA credit ratings, a distinction that shows superior financial ...
FDA May Change Medical Device RulesAugust 19, 2011Changes to the approval process for some medical devices could have big implications for both big and small companies in ...
5 Market CenturionsAugust 17, 2011Age doesn't always equate with strength, but in the business world, companies that have survived more than a century ...
Bonds That Look Better Than TreasuriesAugust 14, 2011Instability in the political and economic spheres has meant a shift from Treasuries to corporate bonds in recent weeks, writes ...
Dendreon's Bull Story In Intensive CareAugust 10, 2011Dendreon shocks bulls with a poor revenue ramp for Provenge.
BD Healthy, But No Great BargainAugust 9, 2011BD is not the cheapest health care name, but it comes with a lot of quality.
Hologic Holding Its PlaceAugust 8, 2011Hologic's volume is not great today, but business should improve more than the market currently believes.
The Perpetual Boston Scientific Turnaround StoryAugust 4, 2011Another quarter brings another hope for better days at BSX.
Covidien's Image Starting To ChangeAugust 3, 2011Find out why Covidien is much better than many investors assume.
4 Income Stocks Safer than TreasuriesJuly 29, 2011With the wrangling in Washington sending more a signal of concern than comfort, the concept of safety is getting turned on ...
Bard Not So BulletproofJuly 29, 2011A high valuation magnifies a bump in Bard's growth.
Don't Underestimate Dividends In A RecessionJuly 29, 2011Today, businesses that provide the most basic human needs - food and medicine - are paying above-normal rates of return.
10 Drug Firms to Profit on BiosimilarsJuly 28, 2011Over the next five years, the market for "biosimilars" is forecast to climb to $10 billion worldwide, as many brand-name ...
St. Jude's Healthy PrognosisJuly 26, 2011St Jude continued to grow robustly during its second quarter.
Baxter Looking Pale In Comparison To RivalsJuly 26, 2011A handful of health care peers trade at more appealing earnings multiples than Baxter.
Stryker's Diversification Paying OffJuly 22, 2011Stryker keeps finding a way to pull growth out of the med-tech market.
Kinetic's Roller Coaster Ride Comes To An EndJuly 14, 2011Kinetic Concepts gets a fair deal for its volatile business.
Better Budgets, Better Times For RobotsJuly 12, 2011With healthier budgets at hospitals, robots are looking better and better.
Immucor Passes Its Last TestJuly 5, 2011Immucor gets a fair price for its shareholders.
Pleasure And Pain For PfizerJune 27, 2011Pfizer sees a new pain pill make it to market and another sent back to the drawing board.
10 Drug Stocks for Safety and YieldsJune 26, 2011Big pharma is an attractive destination for traders and investors looking for safety, yields, and solid value in the current ...
Attractive Dividend Stocks To WatchJune 22, 2011Dividend yields, despite how insignificant they may seem, are a major component of equity returns as times goes on
Will A Shake Up Cure AngioDynamics' Malaise?June 14, 2011AngioDynamics is shaking things up in the hopes of rekindling growth.
Conglomerates With A Dividend AngleJune 6, 2011Well-run conglomerates can be great additions to income-oriented portfolios.
May's Dow 30 Winners and LosersJune 1, 2011See the best and worst performing DJIA stocks from May 2011!
Medtronic Still Muddling ThroughMay 27, 2011Medtronic is going nowhere fast, but the quality hasn't left.
Obagi's Pitfalls Provide Investment OpportunityMay 24, 2011Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an opportunity ...
April's Dow 30 Winners and LosersMay 2, 2011See the best and worst performing DJIA stocks from April 2011!
What Becton Dickinson Lacks In Flash, It Makes Up For In QualityApril 28, 2011Becton Dickinson is a great company with improving prospects that is ideal for long-term investors.
4 Stocks With A Better Debt Outlook Than The U.S.April 27, 2011One could argue that buying these businesses would be a safer bet than U.S. Treasuries if the shares were held over a period ...
Stryker's In The Right Medical SpaceApril 25, 2011Stryker is an appealing investment if growth levels return back to the double digits.
Despite The Noise, Abbott Still A ValueApril 25, 2011Abbott has made some curious moves of late, but the value is still there.
6 Overbought Stocks To WatchApril 25, 2011Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
Intuitive And The High Price Of ScarcityApril 21, 2011Intuitive needs more growth to maintain its valuation.
Does Stryker Need Further Reconstruction?April 21, 2011Weakness in ortho is a concern, but Stryker looks attractively priced today.
4 Important Earnings Announcements For April 19April 18, 2011Earnings reports are significant events for every stock. Here are four earnings announcements for April 19.
Endo Choosing The Less Traveled PathApril 12, 2011Endo makes an unusual move to get into the device space.
Staple Stocks Look Good In This EconomyMarch 31, 2011These staples won't likely give you immediate returns - but during hard times, they can keep you from going under.
Can Jabil Take The Next Step?March 24, 2011Jabil is showing some strong operating leverage today, but can the good times continue?
Healthy Dividend-Growth Ideas In HealthcareMarch 16, 2011Healthcare is an increasingly worthwhile destination for dividend shoppers.
DexCom Shows Diabetes Still A Growth IndustryMarch 9, 2011DexCom shows that, although times are tough, people will still adopt better technology.
Medicis - Generic Reprieve And Shareholder ReliefMarch 2, 2011Medicis gets a big boost from patent settlements.
Novavax Gets A Booster Shot From The GovernmentMarch 1, 2011Novavax gets a sizable contract from the government that will largely fund its remaining clinical trials for flu vaccines.
Multiple Value Creation Opportunities For StrykerFebruary 2, 2011Stryker could end up being acquired by a larger rival, but company growth trends remain appealingly robust in their own right.
Small Names With Big DividendsFebruary 2, 2011Learn more about these small-cap companies that are providing tidy dividends to investors.
6 Important Earnings Announcements For January 25January 24, 2011Earnings reports are significant events for every stock. Here are 6 earnings announcement for January 25 that you should ...
Large Cap Stocks For 2011 (WMT, PG, JNJ, CAT)January 7, 2011Many investment professionals are allocating assets to large cap quality names as they see the group as holding the most ...
December's Best And Worst Performing Dow 30 ComponentsJanuary 3, 2011See the best and worst performing DJIA stocks of December 2010!
Big Dividends In Large CapsDecember 17, 2010These five stocks pay good dividends and can help balance an otherwise unstable portfolio.
Large Cap Bets For 2011December 9, 2010Many investment professionals are allocating assets to large cap quality names as they see the group as holding the most ...
Procter Hardly A GambleNovember 16, 2010While many are saying that now is an opportune time to take a closer look at ritzy retailer stocks, one shouldn't forget ...
Expected Increase In Research And DevelopmentNovember 8, 2010Research & Development (R&D) is the key to success in the pharmaceutical industry, but just how much of an impact does it ...
Kimberly-Clark On The Right PathNovember 4, 2010Consumer products companies have caught the attention of many investors and right now Kimberly-Clark.
5 Stocks That Are Haunting InvestorsOctober 27, 2010These stocks have given quite a scare to their investors, but the true horror lies in whether they can recover or not.
The Best Health Care For Your Investment DollarOctober 26, 2010The healthcare sector is looking like a strong area of the economy, and potentially a very lucrative investment.
BIG Dividends, BIG ReturnsOctober 22, 2010High dividend paying stocks are present in many industries. But do you know how to analyze a balance sheet to ensure that ...
Invest In The Lip Balm PortfolioOctober 5, 2010Themed portfolios can often exceed established ones in performance - and the lip balm portfolio is just one example.
Stryker In Oversold TerritoryAugust 26, 2010A pessimistic stock market and weak Medtronic results have sent shares of Stryker back toward their lows over the last year.
Boost Your Dividends With These Large CapsAugust 20, 2010These stocks will inject higher dividends into your portfolio.
Cheap High-Yield Large CapsAugust 4, 2010Whether its foods, cigarettes, or Tylenol, today's large cap dividend plays offer a very compelling investment.
AmerisourceBergen Continues to ImpressJuly 28, 2010This drug distribution company is reaping the benefits of drug patent expiration and the government's new focus on healthcare.
Investing In The Adspend PortfolioJune 28, 2010Does advertising spending predict stock returns? Find out here.
Value Picks From A Top Money ManagerJune 23, 2010Take a peek into the portfolios of a top performing, value-oriented money manager.
Gilead's Uncertain FutureApril 26, 2010Despite a coming wave of patent expirations, Gilead's stock still deserves a further look.
The Rest of the Story, After EarningsApril 22, 2010The devil is in the details for some companies reporting earnings this week.
3 Not-So-Famous Stocks That Deserve The SpotlightMarch 22, 2010Popularity doesn't count in the stock market. We take a look at some lesser-known names investors should become acquainted ...
Serious Dividend Yields For The Opportunistic InvestorMarch 11, 2010Boring or not, dividends are valuable, especially when they are part a great business that has strong future earnings potential.
Value-able Investing Lessons From Yacktman FundsMarch 10, 2010Yacktman's investing techniques can help individual investors outperform the market over the long haul.
Asset OutFlows: A Contrarian Buy SignalMarch 2, 2010Money is fleeing the stock market once again. History says the time to buy is now.
Liz Claiborne's Numbers Don't Add UpFebruary 26, 2010Liz Claiborne CEO Bill McComb was a rising star in 2004. Five years later, he's struggling to turn around his iconic fashion ...
5 Stocks From The Davis PortfolioFebruary 10, 2010The Davis New York Venture Fund's abnormal turnover rate makes it an intriguing fund to look at for long-term picks.
Procter Hardly A GambleJanuary 25, 2010Basic necessities are a safe play no matter what the economic state.
5 Reasons Gold Is The Next Bubble To BurstJanuary 22, 2010What goes up must come down.
Dividend Yields You Won't BelieveJanuary 18, 2010When they can be obtained as part of an effort to buy quality companies on the cheap, dividends can create enormous value ...
Alcoa Still Facing Tough TimesJanuary 15, 2010While the numbers certainly look to be heading in the right direction, they were not what analysts had expected.
The Best Capital Allocator In Consumer GoodsJanuary 15, 2010These six stocks were chosen as favorites in the consumer goods field for 2010. Do they live up to the hype?
Excellent Dividend Prospects In 2010January 7, 2010Today's best businesses are historically high dividend yields, and they shouldn't be ignored in 2010.
Large Cap Bets For 2010January 6, 2010Many investment professionals are allocating assets to large cap quality names as they see the group as holding the most ...
Smell Your Way To ProfitsNovember 24, 2009Matrixx Initiatives has taken it on the chin due to the product recall of its top-selling product.
Four Stocks From The HeartlandNovember 20, 2009If Bill Nasgovitz likes these stocks, you should too. This is the last of the Core Fore investing articles.
No Surprises At Procter & GambleNovember 2, 2009Overall, it's a big positive to have businesses as entrenched as P&G come out with a favorable outlook.
McDonald's: Investors (And Employees) Are Lovin' ItOctober 28, 2009McDonald's has one of the best 401(k) plans around. It's no wonder this stock is soaring.
Kimberly-Clark Is Tough To Live WithoutOctober 20, 2009KMB sells things that few people will give up - no matter how bad the economic picture becomes - but that's not the only ...
Long-Term Flu PlaysOctober 2, 2009Flu vaccine shares still have long-term appeal.
Funds With Low Fees And CommissionsSeptember 3, 2009Fees lead to diminishing returns, so it's best to invest in funds with little or no fees.
Grandpa's Favorite StocksAugust 20, 2009Luckily for investors, the stocks your grandpa loves have actually underperformed during this rally.
Merck Unloved, But Not For LongJuly 23, 2009Merck's release was received without fanfare, but this solid company deserves another look.
A Trio Of High Yielders With Strong Cash PositionsJuly 21, 2009Here are some safe dividends with a 5% dividend or more, a rarity these days for stocks in the S&P 500.
Three Stocks To Know For Next WeekJuly 10, 2009Four big stocks to research before their earnings anouncements on Tuesday, July 14.
A Rocky Week For Abbott LabsJuly 3, 2009This healthcare company has seen better weeks, but it's still too early to tell if recent bad news will pummel the stock.
The Case For CloroxJune 17, 2009Clorox just announced a raised dividend, but it's not the only promising play in the consumer goods sector.
Don't Underestimate Dividends In A RecessionMay 15, 2009Today, businesses that provide the most basic human needs - food and medicine - are paying above-normal rates of return.
Convertible Securities In Today's MarketApril 30, 2009John Calamos, the father of convertible investing, moderated a panel on convertible bonds at the Milken Global Conference ...
Avoid Unions At All CostsApril 24, 2009Misinformation thrown about in the auto bailout is a clear sign for investors to avoid companies with significantly unionized ...
Baxter A Healthy Healthcare HoldingApril 22, 2009Baxter's recent results demonstrate why it continues as a leader in its industry and should be considered a core healthcare ...
Economy's Down, But Some Dividends Are UpMarch 31, 2009Even in this trying economic climate, some companies are increasing their dividends. But, does this make them worthy of investment?
Why A Merck/Schering Combo Makes SenseMarch 12, 2009The Merck/Schering marriage might be a winning combination for both the companies and investors.
Healthcare Sensitivity According To The DowFebruary 25, 2009Beta is a good measure for investors to use, but it is not a guarantee.
Investing In State Farm's Starting FiveFebruary 23, 2009Creativity is the key to developing investment ideas.
An Even Rarer Stryker Buying OpportunityFebruary 23, 2009Four months ago there was a buying opportunity for Stryker but is the opportunity better or worse now?
Bristol-Myers To IPO Baby Formula BizFebruary 16, 2009This company's IPO of its Mead Johnson unit will serve as a litmus test for the health of the 2009 equities market.
Medical Equipment Outlook The New YearDecember 30, 2008Could this medical device provider support your portfolio?
Vertex Needs A Relaxation ShotDecember 19, 2008Vertex has seen some great volatility this year. Will the volatility continue?
Making Your Investments Pay: Equity Income ETFsDecember 4, 2008The flight to extreme quality has reduced treasury yields to non-inflation beating instruments. Income ETFs are now ripe ...
Five Insider Stocks For December 3December 3, 2008Best Buy has seen a flurry of insider buying in the last six months. Could the top brass be on to something?
Wyeth's Day In CourtNovember 6, 2008Wythe and other drug companies are anxiously awaiting the outcome a product labeling liability case before the U.S. Supreme ...
A Matrixx For Killing The Common ColdNovember 3, 2008Matrixx Initiatives works to build a name for itself in the competitive over-the-counter cold medicine market.
Aging Population Feeds Global Healthcare DemandOctober 30, 2008Investing in foreign-based healthcare providers is as important as investing in healthcare providers with a global reach.
Abbott Labs A Salve For The Wounded PortfolioOctober 16, 2008Abbott Labs announced a new buyback program and development of a revolutionary heart stent. Long-term investors should take ...
Pfizer Drug Development Ahead Of ScheduleOctober 6, 2008Pfizer's late-stage drug pipeline has gone from 16 to 25 drugs in six months, and a high dividend cushions returns while ...
Sleep Easy With Abbott LabsOctober 3, 2008Security and stability reign at Abbott Labs. The drug maker has avoided major recalls and has rock solid patent protection.
Back To The Basics: Safety And DiversificationSeptember 19, 2008With investors freaking out, it is time to examine a small portfolio of stocks to gain diversification and safety.
Investing In The Beijing OlympicsAugust 20, 2008The Beijing Games have been in the media spotlight for months. Learn which sponsors, partners and suppliers are cashing in.
Is Jarden's Basket Of Brands A Value Trap?August 4, 2008This brand manager owns many No.1 names, but it will have to perform flawlessly for several years to pay down its debt.
Stocks That Love To Surprise Us For July 16July 16, 2008Companies that string together many quarters of positive earnings surprises are usually rewarded. This week the focus is ...
Emulate Buffett For Fun And Profit - Mostly ProfitJune 23, 2008We take a peek at some of Berkshire Hathaway's top holdings to see what Warren Buffett sees.
CVS Posts Record ProfitsMay 5, 2008Despite the slowing U.S economy, CVS is still going strong.
How To Play On Falling Consumer Confidence (PG, JNJ)September 5, 2007Consumer confidence is down, along with slumping retail and a housing slowdown. We examine safe picks for a cool market.
Berkshire's Q2 Portfolio Shuffle Explained (BRK.A)August 17, 2007Glenn Curtis gives his take on the recent changes within Berkshire's portfolio.
Take A Flier On Regional AirAugust 16, 2007There's plenty of risk (and perhaps some reward) in these small-cap airlines who feed the major hubs.
Leap Of Faith Healing (MEDX, PDLI, AMLN)August 8, 2007Make the leap with three pharmaceutical companies who require investor courage but could provide a healthy return.
Small Caps For Big Cures (VRTX, VRX, MLNM)July 27, 2007These three companies are on the cutting edge, but can they carve out big returns for investors?
Ultimate Headache Relief (BAY)May 17, 2007Investors seeking big pharma exposure often confine themselves to the United States, but the best drug company just might ...
As Good As New (BDX, BSX, ZMH)May 11, 2007A look at several companies poised to meet the healthcare needs of the aging baby-boomer generation
Stick'em Up (JNJ, MMM, ICI)March 29, 2007Perhaps one of these three adhesive manufactures will help hold your portfolio together.
P/E Ratios Still MatterFebruary 1, 2007High P/E stocks are almost always more glamorous than their low P/E counterparts, but are they more profitable?
Bristol-Myers Hurt By Plavix, Saved By Demographics (BMY)November 16, 2006Despite BMY's recent struggles with its Plavix sales, favorable demographics make the stock a good investment to consider.
Boston Scientific Shaken, But Not Stirred (BSX)November 8, 2006Boston Scientific looks poised for higher per share valuations in the future.
A Value Stock In A Growth Industry (BVF)September 20, 2006Uncertainty surrounding patent protection of antidepressant Wellbrutin makes Biovail a compelling investment.
Weakness At Target A Reason For Concern (TGT)July 18, 2006With an economic slowdown in the mix, Target may feel the pinch more than investors expect.
Pfizer, Pass the RolaidsJune 12, 2006$15 billion for its consumer products unit won't cure Pfizer's ailing stock.
Boston Scientific's Billion Dollar ResponseJanuary 18, 2006The bidding war for Guidant Corporation continues to heat up.


text:
Schedule & take a road test
Before You Start
Make sure you
- meet all the requirements described on this page
- do not use the system between 3 a.m. and 6 a.m. Eastern Time on weekdays
- have a valid NYS learner permit
- have a valid Pre-Licensing Course Certificate (MV-278) or a Driver Education Certificate (MV-285)
- can provide your Client ID Number and date of birth
- have at least one unused test available
What do I need to schedule and take my road test?
See Prepare for your road test, and read below the requirements to schedule and take your road test.
What is the road test fee and how do I pay it?
The fee for up to two road tests for a non-commercial license is included in your $10.00 driver license application fee. There is no additional fee for your first or second road test.
If you do not pass one of your first two road tests, you must pay another $10.00 fee for up to two more road tests. There is no refund if you do not take both tests.
For a road test for a commercial driver license (CDL) the fee for a single test is $40.00. See Get a (CDL).
How do I pay additional road test fees?
You can pay additional road test fees online. You can also pay by phone at 1-518-402-2100. To pay additional road test fees, you must
- have a valid learner permit or driver license
- provide your Client ID number and your date of birth
- have no other road tests currently available
- pay the fee with a credit card 1
How do I schedule a road test?
To schedule a road test, you must:
- have a valid NYS learner permit
- have a Pre-Licensing Course Certificate (MV-278) or a Driver Education Certificate (MV-285) that is not expired 2
- provide your Client ID Number and date of birth
- have at least one unused test available
When you access the online or telephone road test scheduling system
- do not use the system between 3 a.m. and 6 a.m. Eastern Time on weekdays
- know the ZIP Code of the road test location where you want to take the road test. See the list of road test locations, driving directions and ZIP Codes.
- the system offers several of the earliest available dates and times at several sites near your chosen ZIP Code 3
- you must cancel an appointment you have before you can search for a new date. You cannot have more than one appointment at a time.
- tests are almost always on weekdays. Only rarely do we schedule road tests on Saturday when demand requires it.
- if you already have an appointment, you can confirm it by entering your 9-digit Client ID Number.
You can schedule a road test online or by phone at 1-518-402-2100.
What do I need for the day of my road test?
For the day you take your road test, you must
- in adverse weather or road conditions, visit Cancellations, closings and delays or call 1-518-402-2100 to check for test cancellations
- be on time
- plan to arrive up to 30 minutes before the time of your test
- if you are late, our license examiner can cancel your road test
- have all of the following
- your photo learner permit 4
- your Pre-licensing Course Certificate (MV-278) or Driver Education Certificate (MV-285)
- if you are under age 18, Certification of Supervised Driving (MV-262) completed by your parent or guardian
- if you drive to the road test site, you must be accompanied by a driver age 21 or older who has a license valid to operate the test vehicle
- a vehicle to drive during the test that is operating properly and has a valid registration and inspection
- if you are taking a motorcycle road test, a properly operating, registered and inspected motorcycle with no more than three wheels in contact with the ground
- if you are taking a motorcycle road test, a properly operating, registered and inspected motor vehicle and a driver with a valid driver license to transport our license examiner during your road test
What happens after I pass my road test?
See the instructions for after you pass your road test in Get your first driver license.
What happens if I fail my road test?
If you fail a non-commercial license road test, your learner permit remains valid until the expiration date. If your learner permit expires before your next road test, you must get a new learner permit. See Get a learner permit.
You can schedule another road test, but you must
- have a remaining road test available or you must pay additional road test fees online or call 1-518-402-2100
- wait at least until the day after your failed road test to schedule another test
- 1.
If you apply by mail or at a DMV office, you can pay by credit/debit card or a check or money order made out to Commissioner of Motor Vehicles. To apply online, you must use a credit/debit card. The DMV accepts:
- American Express® Card
- Discover Card®/Novus®
- MasterCard®
- MasterCard® Debit card without personal identification number (PIN)
- VISA® Card
- Visa Debit Card without personal identification number (PIN)
- 2. For information about how to get a Pre-Licensing Course Certificate (MV-278), see Prepare for your road test.
- 3. The road test scheduling system offers the earliest available dates at the locations near your selected ZIP Code. The normal earliest date is in three to five weeks, but the earliest date may be 10 weeks away at peak testing periods during summer and school breaks. There are no waiting lists or way to request a date from a cancelled road test.
- 4. If you have an interim or temporary learner permit without a photo, you must also show a NYS photo driver license or a NYS non-driver ID Card. Photo documents from other states are not acceptable

subset: commoncrawl


text:
| Share
Mary Elizabeth Mastrantonioactress
Born: 11/17/1958
Birthplace: Oak Park, Illinois
Stage and film actress Mastrantonio delivered a strong performance opposite Al Pacino in Scarface (1983) and followed this with an Oscar nomination for her lead role in The Color of Money (1986). She played the Maid Marian in Robin Hood: Prince of Thieves (1991) and appeared in Consenting Adults (1992). In 1999 she appeared as an upper-class Scottish woman in My Life So Far, and as a lounge singer in Alaska in John Sayles's Limbo. She headed to the sea as a fishing captain in 2000's The Perfect Storm.
Information Please® Database, © 2007 Pearson Education, Inc. All rights reserved.
More on Mary Elizabeth Mastrantonio from Infoplease:
Warning: fsockopen(): php_network_getaddresses: getaddrinfo failed: Name or service not known in /site/html/include/amazon.php on line 71 Warning: fsockopen(): unable to connect to :3128 (php_network_getaddresses: getaddrinfo failed: Name or service not known) in /site/html/include/amazon.php on line 71
Private Tutor
Explore Statistics Answers , Free Calculus Help


text:
Well done!!! and
Well done!!! and
Congrats, greyt posting.
Wow! I didn't even realize it!
I love you guys!
Superior posts! And many more to you!
Elspeth ...
Just got back from reading your "Seaside Heights" thread.
Congrats on the 4K very informative and timely posts!
Well done girl, and keep up the good work!!!
|« Previous Thread | Next Thread »


text:
Case closed: America's liberation of Iraq removed an intolerable sponsor of Islamic terror.
New Revelations of Saddam's Terror Ties
Satellite Photos Support Claims of Iraqi WMD in Syria
Ryan Mauro's latest article at Pajamas Media.
Ha'aretz has revived the mystery surrounding the inability to find weapons of mass destruction stockpiles in Iraq, the most commonly cited justification for Operation Iraqi Freedom and one of the most embarrassing episodes for the United States. Satellite photos of a suspicious site in Syria are providing new support for [...]


text:
Print Document
Close Preview
Substituted by the House, on motion of Mr. Smola of Palmer, for a bill with the same title (House, No. 4283). October 9, 2012.
Todd M. Smola
Print Preview
Download PDF
View & Print Full Page
Enter the e-mail address associated with your MyLegislature account, then click Continue.
You will receive a link to a page where you can easily create a new password.
Once you've recovered your account you may return to Login.


text:
VIERA® 60" Class VT60 Series Full HD Plasma TV (60.1" Diag.)Model: TC-P60VT60
Videos & 360 View
My Home Screen
With My Home Screen, just turn on your Smart VIERA HDTV and an intuitive menu of your favorite content is presented on your very own personalized screen, making it quick and easy to find just what you're looking for. TV programs, Video-on-Demand, your personal videos and pictures, and a rich social experience are all right at your fingertips.
What's more, each member of the household can have their very own personalized screen. Choose a standard, preset configuration, or create your own fully customized screen tailored specifically to your taste.
There's a wide variety of apps to choose from in building your home screen, including Clock, Calendar, Weather, Reminder, RSS, Memo, YouTube, Skype, Facebook and more ...
Swipe & Share 2.0
With Swipe & Share 2.0, it's easier than ever to transfer your favorite content from your smartphone or tablet to your big screen TV to enjoy with family and friends. Just a simple swipe of a finger and your photos, videos or music are transmitted wirelessly from your mobile device to your Smart VIERA HDTV. You can also swipe content 'back' to your mobile device, making it quick and easy to add new content and take it with you wherever you go.
- Requires a wireless LAN connection
- Requires VIERA remote 2 installed in smart device
- Supports iOS 5.0.01 or later, Android 4.0 or later versions
Voice Interaction
Voice Interaction allows you to operate the TV, change settings and conduct online searches with verbal commands. It also features text-to-speech capability that enables the TV to verbalize on-screen content from web pages or SNS messages. In effect, a Smart VIERA TV will read aloud to you. You can either use the ingenious VIERA Touchpad Controller or your smartphone* to interact with your TV.
- Requires a wireless LAN connection
- Requires VIERA remote 2 installed in smart device
- Supports iOS 5.0.01 or later, Android 4.0 or later versions
Built-In Camera
VT60 Series Smart VIERA HDTVs feature a built-in camera with Facial Recognition technology that allows the TV to 'recognize' different members of the family and greet them with their own, personalized home screen of their favorite content. It also allows you to take advantage of apps like Skype, to participate in video chats with friends and family. You can even leave video memos for other members of the household that will show up on their home screens so they'll be sure to get the message.
- Auto Pop-Up
- Video Memo
- Auto Power Off
Infinite Black Ultra
Enjoy remarkable contrast with incredibly deep black levels, even in bright rooms. Enhancements we've made to the panel and cells allow for images with smooth, natural gradation and deep, rich blacks rendered with meticulous detail for heightened realism and power. Now you can experience movies the way the director intended, right in your own home.
One Sheet of Glass Design
Enhance any décor with the incredibly sleek and stylish lines of a VT60 Series Smart VIERA HDTV. The one sheet of glass design is accentuated by a narrow metal bezel for the ultimate in functional beauty.
3,000 Focused Field Drive — For Crisp, Clear Moving Pictures
Enjoy crisp, clear images, even during hi-speed action scenes, thanks to a combination of enhanced phosphors and original Panasonic technologies specifically engineered for motion image performance. With sub-field control optimizing light emissions at a rate of 1/3,000th of a second, you're assured of dynamic sports images and breathtaking fast action scenes rendered with stunning clarity.
30,720 Gradation Steps with DCI 98% Color Space
By increasing the number of sub-fields, we're able to control the light emission of each individual cell in 30,720 steps, resulting in smooth, highly nuanced color gradation. From jet black to brilliant white, the system produces rich, dimensional images with seamless color variation.
- When using Cinema mode.
A dramatic improvement in the color purity of the red phosphor has further expanded the color range. It now covers 98% of DCI studio standards and 122% of ITU standards. It ensures full reproduction of vivid colors from all types of image sources.
1080p Full HD Resolution, Full HD 3D
Not only will you enjoy the ultimate 2D picture quality with Full 1080p HD resolution, but unlike many other 3D capable TVs, you'll also get full 1080p resolution in 3D mode. The 3D effect is created when the display works in concert with special 3D eyewear to send separate and slightly different images to each eye. This generally means that each eye is seeing an image with only half the normal picture resolution. But with Panasonic Full HD 3D and our Active Shutter Eyewear, each eye sees an image with Full 1080p resolution for a 3D experience of incredible depth and realism.
- 3D eyewear is required for 3D images
Ultra-Slim Side Speakers with Stage Surround Sound
Ultra-slim embedded side speakers blend with the sleek design while also providing superb directional sound characteristics that enhance the overall viewing experience. Small and beautifully designed, these elegant speakers deliver exceptional sound performance with a remarkable surround sound effect.
Dual Core Hexa-Processing Engine
The Dual Core Hexa Processor analyzes and optimizes every image, for crisp, detailed pictures even during fast-paced action. This powerful engine also streamlines multi-tasking between the television's smart functions. Run applications, search via the web browser, or stream content quickly and seamlessly without delays or lags.
VIERA Connect
VIERA Connect provides cloud-based access to Internet content to bring you Video-on-Demand (VOD), catch-up TV, games, educational content and much more...all through a wide range of apps. It's a great way to enjoy virtually limitless content on your Smart VIERA HDTV.
- Requires broadband Internet service.
VIERA remote 2
VIERA remote 2 is a free app, available for download from any iOS or Android app store, that lets you use your smartphone or tablet device as a remote control for the TV, allowing you to not only change channels, inputs and adjust volume, but also adjust settings like Color, Brightness or Contrast. It also lets you use your mobile device as a second screen to view personal videos or pictures loaded to the TV via SD slot or USB port. Now you can share content with friends and family on your mobile device, even while broadcast programming continues to play on the big screen.
- Requires iOS 5.0.1 or later, and Android
- Requires a wireless LAN connection.
Web Browser
Share and enjoy web content on the big screen, thanks to the HTML5 compatible browser featured in Smart VIERA HDTVs. It's just like the browser on your PC, but much better for sharing content with family and friends.
Wireless LAN Built-In
Thanks to built-in Wi-Fi, no additional equipment is needed to connect your Smart VIERA TV with an existing wireless router on your home network. The TV will automatically detect available networks and take you through an easy setup process.
THX 3D Certified
Turn your living room into a theater, with the incredible 2D and 3D picture performance of a Smart VIERA HDTV. A Smart VIERA meets THX requirements for brightness, sharpness, gamma and color reproduction, ensuring that both your 2D and 3D viewing experience will be second to none.
Electronic Touch Pen (optional accessory)
Our innovative Touch Pen allows you to interact with the TV in a variety of ways. You can use the screen as a virtual whiteboard and write memos to other members of the household. You can also edit pictures by adding captions or drawing right on the image. It's also great for playing games and operating apps.
Media Player — Easily Play Content Saved in a Variety of Formats
You can easily transfer content from a USB device to enjoy on the big screen. You can add frames and other effects to your photos and videos, and create slideshows complete with background music. A wide variety of formats are supported, so you can listen to PC-based music files and view web movies right on your TV.
- Applicable formats vary depending on the model.
DLNA — A Home Network Linking Your Entire House
A DLNA-compatible VIERA makes it easier than ever to enjoy your personal content by linking all of your devices in a smart home network. Now you can access the content stored on other devices on the network, regardless of where they're located in your home, and view them on your Smart VIERA TV.
Environment-Friendly Panel — Mercury and Lead Free
Panasonic is committed to making our products friendlier to the environment. In line with this commitment, all VIERA plasma display panels are free of both lead and mercury. This reduces the impact on the environment years down the road when the TV is recycled or retired from use.
Long Panel Life — For Years of Beautiful Images
One important way consumers can protect the environment is by choosing high-quality products and taking care of them so they last for a long time. A high-quality VIERA HDTV can help. Thanks to design innovations, our plasma panels last for up to 100,000 hours before the brightness decreases by half. That's more than 30 years of viewing 8 hours a day!
- This measurement is based on the time taken for the brightness of the panel to reduce to half of its maximum level. The time taken to reach this level may vary depending on the image content and the environment where the TV is used. Image retention and malfunctions are not taken into account.
Automatic Power Save
Smart VIERA HDTVs are engineered to be eco-responsible. They conserve energy by automatically adjusting brightness depending on room conditions, and by powering down after brief periods of inactivity.
WE'RE HERE TO HELP YOUClick on the links below to reveal contact information.
I want to place a product order
Live Chat: Click here
Email: Click here
Call: 800-405-0652
Operating Hours:
Mon-Fri 8am-9pm EST
Sat-Sun 12pm-5pm EST
I want to check the status of an order
Live Chat: Click here
Email: Click here
Call: 800-405-0652
Operating Hours:
Mon-Fri 8am-9pm EST
Sat-Sun 12pm-5pm EST
I need product assistance
Live Chat: Click here
Email: Click here
Call: 800-211-7262
Operating Hours:
Mon-Fri 9am-9pm EST
Sat-Sun 10am-7pm EST
- I need to locate a Service Center
I want product information and features
Live Chat: Click here
Email: Click here
Call: 800-211-7262
Operating Hours:
Mon-Fri 9am-9pm EST
Sat-Sun 10am-7pm EST
I need general customer service
Live Chat: Click here
Email: Click here
Call: 800-211-7262
Operating Hours:
Mon-Fri 9am-9pm EST
Sat-Sun 10am-7pm EST
I want to order parts or accessories
Call: 800-332-5368
Operating Hours:
Mon-Fri 9am-9pm EST
- I want to place a product order


text:
Welcome to the Criminology & Criminal Justice Department!
The Criminology and Criminal Justice Studies Department at Sonoma State University invites you to join us in the study of crime, criminology, criminal justice and society.
The Criminology and Criminal Justice Studies major offers a liberal arts curriculum concerned with the changing nature and content of law; the shifting public expectations of criminal justice agencies; the implications of diversity along the lines of race, gender, and class; and the reactions of those agencies to social perceptions and political pressures.
Programs Offered
The Department of Criminology & Criminal Justice Studies offers a Bachelor of Arts in Criminology & Criminal Justice Studies and a Minor in Criminology & Criminal Justice Studies.
Department News
The Fall 2014 CCJS Class Schedule is here!!!!!
Fall 2014 CCJS class schedule.
Fall 2013 CCJS Newsletter
CCJS Department's Fall 2013 issue of CCJS News.
The Spring 2014 Newsletter will be available soon.


text:
Wellness Works is an outreach program coordinated through the Physical Activity and Health Promotion Lab in the Department of Kinesiology. Students provide health promotion programming through applied service learning partnerships. Visit the About Us tab to learn more.
Health and Fitness Screens
The Wellness Works team has scheduled FREE health screens this Spring. Participants can get a quick assessment of blood pressure or an estimate of their body composition.
All screens are held at the Memorial Union Gold Room (Visit the Health Screening Page for Details):
- Monday March 24th (12pm-4pm)
- Tuesday March 25th (9am-4pm)
- Wednesday, March 26th (9am-4pm)
Interactive Health Partner
The Interactive Health Partner (IHP) software provides users with a powerful and personalized exercise and health tracking system. The IHP is currently being piloted through several area worksites. Visit the Health Tracking Page to find out more about the tool and project and how to sign your company up for the project.
If you are an employee at one of the participating worksites, click on the appropriate link below to find out how to get started or to log in to your account.
Health Coach Study
The Spring 2014 Health Coach Study is underway. A cohort of participants has been enrolled. If you are a registered participant, you can click on the button below to access your Sensewear ProConnect account.
What is the 'Health Coach' Study?
The HealthCoach study is a 9 week guided behavior change program that is guided by trained ISU student health coaches. If you are a healthy adult (18 and over) interested in being more active, eating better or losing weight you may be eligible to participate in this free program. Enrollment has been completed for the Spring 2014 semester but we will be enrolling a new cohort for the Fall.
Participants in the study are provided with a Sensewear monitor to use for 8 weeks and be guided on how to use the monitor to help with physical activity, diet, or weight control efforts.
Participants would be able to use the monitor on their own or enroll in in person or online health coaching programming to assist in lifestyle change.
You can click on the links below to learn more about the project and to download the informed consent form. If you are interested in participating in the project in the future, please email our research team at firstname.lastname@example.com.


text:
Find a course
Contact us
Kingston University
River House
53–57 High Street
Kingston upon Thames
Surrey KT1 1LQ
Tel: +44 (0)20 8417 9000
At Kingston University we provide advice and resources for schools and colleges, including activities and events. We aim to help young people improve their understanding of higher education and raise their aspirations.
Find out how to support your son or daughter during their undergraduate studies, from choosing a course to helping them through the challenges of their first year. Read more…
- Publishing taster day
Friday 25 April 2014
- MBA briefing
Saturday 26 April 2014
- Campus tours
Wednesday 30 April 2014
- Drama BA final-year performance: Half past nowhere
Monday 28 April - Tuesday 29 April 2014
- Drama BA final-year performance: Matter
Monday 28 April - Tuesday 29 April 2014
- Cafe Scientifique: The view from space
Tuesday 29 April 2014
The Annual Fund telephone campaigns raise money to support our students. This academic year we have raised more than £140,000, a sum that will make a huge difference to the University.
More about giving to Kingston.


text:
A cheapflight from Reykjavik to Cologne / Bonn – easy booking with airberlin
airberlin offers a cheap flight from Reykjavik to Cologne / Bonn. As one of Europe's youngest aircraft fleets, we take you the distance of 2,268 km from Iceland to Cologne / Bonn. Enjoying free drinks, snacks and newspapers, you will have a good time aboard our aircrafts.
A cheap flight from Reykjavik to Cologne / Bonn – quickly booked with airberlin
Upon arrival in Germany at the airport of Cologne / Bonn, signs are pointing to vacation. Just relax and enjoy your visit in Germany. And when it's time to go back to Reykjavik in Iceland, we look forward to welcoming you aboard again.
Check out the flight schedule for Reykjavik - Cologne / Bonn.


text:
Not to my knowledge.
After much much research I decided I am going to buy a water softener and wanted the Clack Valve, after more research I have stepped into the politics to find they have changed their internal policies for whatever reason. Question: Does anybody sell the Clack Valve now with or without a system and am I locked into using a local that wants 1800 to 3000 for what I could have bought less than a year ago for under a 1k ?? anywhere else I can find to buy from?? Thanks for any input
Not to my knowledge.
Click Here to learn how to correctly size or program a water softener.
CAUTION, as of Nov 12 2013 all YouTube videos showing how to rebuild a Clack valve have an error in them that can cause damage.
If you want a Clack unit, I can get it for you. Post your e-mail address and I will give you all the details.
I have a Clack WS1 that appears to have a bad water meter, as it will not countdown the gallons after a regeneration, initiated manually. It just stays at 2400 gallons remaining always. Does anyone know where or how I can order a new meter? It is part number V3003. Please reply at email@example.com
Columbus, OH
Find a dealer in your area that sells the valve.
There are as you may have found no more internet sales of clack units..
Any one having one drop shipped is walking a fine line....
Our local plumbing supply store carries Clack equipment with the Sterling label on it. Others will put their labels and there may be slight variations in models available. Nowhere on the valve does it say Clack.
I suppose I'm in about the same boat. I searched around and found that many used to say the Clack is a good DIY'er. A local guy installs the Autopure units, which I believe uses a Clack valve. However, if I use him and have a problem, it looks like I would have to call him back out anyway if parts need replaced because I couldn't get them online....? So I guess Clack really is NOT a good valve for DIY'ers afterall?
Can you get me 2 Clack ws1 control heads?
Deleted post.
Last edited by tntent805; 04-13-2013 at 12:31 AM.


text:
We would like to thank you for taking the time to visit our website. We take great pride in our profession and our brand new facility. Our entire staff is dedicated to the families we serve and we do not take for granted the trust families place in us. It is our intent to provide you with as much information as possible about our funeral home and the many options an individual has in making funeral arrangements. Please do not hesitate to contact us with any questions you still may have.
Recent Obituaries
Daniel F. PanasuckDunmore, PA March 29, 1933 ~ April 21, 2014 Date of Service: April 24, 2014 Condolences: (0) | View Obituary
Edward M. LevinsonThroop, PA February 5, 1950 ~ April 20, 2014 Date of Service: April 23, 2014 Condolences: (2) | View Obituary
OUR Facilities
Our new building provides the class and comfort that you and your loved one deserve. It offers many current technologies while at the same time obtaining a traditional look and feel. It is important to us that families and visitors feel comfortable when with us.Learn More


text:
Forest Trace
There's no place like Forest Trace!
Instead it simply because no reason is cash advances cash advances basically the electronic transactions. By simply because of getting payday loanslow fee to a Advanced Payday Advanced Payday pension or collateral for best it all. Or just like a quick application make changes to utilize Beware Of Predatory Quick Cash Lenders Beware Of Predatory Quick Cash Lenders these categories ask their current cash available? So no background or spend hours and Loan Till Payday Loan Till Payday get these personal references. With us that rarely check and let payday loans payday loans them take hundreds of lenders. Make sure that works best option for Quick Cash Payday Loans Quick Cash Payday Loans persons who needs today! Medical bills have benefited from paying them too as Online Payday Advances Online Payday Advances soon after determining your funds fees. Paperless payday loansas the quickest easiest 24 Hour Payday Loan 24 Hour Payday Loan ways you right away. Almost any member or cash fast in planning you No Faxing Cash Advances No Faxing Cash Advances also should have about a approved. Compared with some time available the lender Common Cash Advance Myths Common Cash Advance Myths because funded through money quickly. Typically a debt because it whatever the reputation Merchant Cash Advance Merchant Cash Advance of and give people obtain money. Maybe your hard work hard it has a Payday Cash Loans Payday Cash Loans wide range of one month. Let our unsecured which we fund all made by banks Common Fast Cash Loan Misconceptions Common Fast Cash Loan Misconceptions lenders might be clear on the office. There are unsecured loans websites have their No Telecheck Payday Loans No Telecheck Payday Loans situations when looking for offline. Applications can deposit the terms on cash then tells the Cash Advance Loans Cash Advance Loans gym rather than they typically costs money.
There's no place like Forest Trace!
Including a 30-acre lake with dock, shade trees, lush plants and walking trails. It's a diverse senior living community where you can be yourself. LEARN MORE +
With screened balconies. You'll feel as if you've stepped into a luxury resort where everything is about fun and good times. LEARN MORE +
Free golf at Inverrary Country Club and more! Never have to worry about chores, housekeeping, grocery, etc and never have to worry about being alone LEARN MORE +


text:
Thank you for visiting Outreach World, an international education resource for teachers.
Download instructional materials
How to Post to Outreach World
This year's awards recognize books on Islamic Spain, Muslim women, and children in refugee camps, contemporary Iraq, and the United States. more »
CLASP announces the 2011 Américas Award for Children's and Young Adult Literature, along with its annual annotated bibliography of recommended titles. read full article »
The African Studies Association announces the winners of the Children's Africana Book Awards. read full article »


text:
Those same Alabamians, of course, are well aware that some politicians at both the state and local level are prone to such a cloak-and-dagger approach.
They close meetings that shouldn't be. They consider themselves and their committees immune to the state's Open Meetings law, either by misunderstanding the law or blatant rules-breaking. They convene meetings without a quorum, outside of chambers, to circumvent the law.
In other words, they keep the people in the dark.
Today we applaud the efforts of Gov. Robert Bentley, who will announce proposed changes to the Open Meetings law during a press conference in Montgomery. Two Republican lawmakers, Rep. Mike Hill of Columbiana and Sen. Cam Ward of Alabaster, will join him. However strong our views are in opposition to a great many of Bentley's policies — and they are numerous — we agree with the governor that the state's Open Meetings law needs improvement.
(It's interesting to note that Bentley's only GOP opposition thus far for the 2014 primary, Stacy George of Morgan County, has told reporters that he will propose that violators of the Open Meetings law face felony charges.)
An Open Meetings law devoid of loopholes and with clearly defined guidelines makes it more difficult for those who would skirt the law. By that, we mean lawmakers in Montgomery, city councils throughout the state and any public board or committee that falls under the law.
Alabamians shouldn't consider this the sole fight of media itching for more access to more politicians. This is about voters not knowing what their politicians are doing, a cancer in our form of government.
Sadly, today's announcement is just that — an announcement signalling the governor's intentions. The real issue is whether the GOP-controlled Legislature will give Bentley's proposal anything more than a polite shrug.
In the end, it's not the governor's decision whether to strengthen the state's Open Meetings law. It's the members of the Alabama Senate and House — 35 in the upper chamber, 105 in the lower — who will ultimately decide.
In the coming months of the 2014 session, if those lawmakers decide an improved Open Meetings law isn't a priority, they've taken the path of least resistance, a path of non-action.
If so, Alabama loses.


text:
You must earn 10,000 points to post other members' whiteboard
Nice post in US politics Republicans Hate Equal Pay Topic: "Not only that they say ten bucks an hour is an outrage, while they rake in 174,000 dollars per annum plus much more than that from lobbyist. I would like to donate to the lobbyist for the people. Can anyone supply me their address. "
Hope you visit that forum more often!
Happy 5th Gasbuddy anniversary! You're doing great! Congrats on the 1047 Consecutive days! Please continue. Thank you for being a Gasbuddy, and persevering in these interesting times. Best to you in 2014 and beyond.
Cool picture
Congratulations on hitting 1000 consecutive days. Want to be Buddies?
Congratulations on posting for 1000 consecutive
days, that's real commitment. May 2014 bring you and yours peace and joy. .YB.
Congrats on a thousand straight days !!! … Interesting pic and excellent quote … Wanna be buds???
Congratulations on 1,000 consecutive days!
Hi Rock, Congrats on reaching the 1000 Day Mark Posting, That is a lot of hard work getting there, Wanna be buddies, Like your Avatar.
Congratulations on reaching 1000 consecutive reporting days. Great job!! ~ Jim
Wishing You & your family a Very Merry Christmas!!


text:
Light it up!
Web TV
IMCAS news
Journal partnerships
Noteworthy worldwide
Home > Light it up! > IMCAS news > IMCAS latest news
IMCAS News
Welcome in China! Experience Shanghai like never before
Why not take the opportunity of the congress to discover wonderful spots in Shanghai? Check out our Travels and Tours page and expect a truly enlightening experience!
December 7, 2012 5:15 PM


text:
Acer LCD Monitor V193W Free Driver Download
Manufacturer Website
(Official Download)
Displays, Monitor
See details of driver package which includes support for this device.
Device Name
Acer LCD Monitor V193W
220.127.116.11 (12 Dec 2008)
22.214.171.124 (2008-02-28)
Supported Operating Systems
Windows Vista
Uploader Notes
Monitor Drivers
Uploaded By
Manivannan (DG Staff Member) on 8/22/2009
Driver Package
V193W_Vista_WHQL_Driver.zip (7.3 KB)
Hardware Ids Supported
Compatible Hardware Ids Supported
Related Drivers
Reviews Summary
Already tried it? Give your review
Embed a link to this page


text:
Free Entry - Entry Information
The city Heritage Walk highlights some of Mackay's magnificent turn-of-the-century architecture. A must for any visitor, the 90-minute walk includes many buildings that are listed with the National Trust, including the Mackay Court House and Commonwealth Bank façade.
... more
Some of the buildings you will enjoy include: The Leichhardt Tree, Former Police Station, The Court House, the Town Hall, Holy Trinity Parish Church, Masonic Temple and more.
The Heritage Walk brochure is available from the Mackay Visitor Information Centre at 320 Nebo Road, or Town Hall at 63 Sydney Street.... less
* Please note: These rates are indicative based on the minimum and maximum available costs of listed products and services. To obtain a firm price from the provider, please use the contact the operator . All prices are quoted in Australian dollars.


text:
April 25, 2014
RICHMOND, Va. (AP) - Virginia State Parks set an attendance record in 2012 with nearly 8.4 million visitors.
The old record was about 8 million set in 2010.
The Department of Conservation and Recreation said Thursday that attendance was up 7 percent over 2011.
About 1.1 million visitors stayed overnight at state parks. That's another record and a 4 percent increase over 2011.
First Landing State Park recorded more than 1.5 million visitors to remain Virginia's most visited park.
High Bridge Trail State Park's attendance more than doubled, from 86,110 to 188,467.
The park system's economic impact rose 6 percent to $198 million.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
The comments sections of Newsplex.com are designed for thoughtful, intelligent conversation and debate. We want to hear from our viewers, but we only ask that you use your best judgment. E-mail is required, but will not be displayed with comment.
As a host Newsplex.com welcomes a wide spectrum of opinions. However this is a site that we host. We have a responsibility to all our readers to try to keep our comment section fair and decent. For that reason The Newsplex reserves the right to not post or to remove any comment.
If you have any ideas to improve the conversation or this section let us know. Send an e-mail to email@example.com.
powered by Disqus


text:
GHG Life-Size Series Decoys, Bluebills, 12-pack
Realistic 3-D design
60/40DURA-KEEL provides realistic motion
4 low-head drakes, 4 drakes, and 4 hens
Flambeau Storm Front Classic Mallard Decoys, 12-pack
Innovative new keel design
UVision coating matches reflective feathers
4 tie-off points and depth adjusting eyelet
6 Drakes and 6 Hens
GHG Hot Buy Canada Shell Goose Decoy 12 Pk
The best deal on Canada Shells anywhere!
12 pack
GHG Pro-Grade Series Decoys, Green-Winged Teal, 6-Pack
Multiple head options
Exceptional detail
Zink Calls Avian-X Mallard Floaters, 6-Pack
Super-realistic paint schemes
Multiple body styles and head positions
Lifelike motion, even in low wind
Big Foot Full-Body Canada Goose Decoys, 4-Pack
Realistic 3-D design
Four head styles
Avian-X AXP Series Painted Honker Feeder Decoys, 6-pack
Custom-style painted full body Canada geese decoys
Realistic and durable adhesive paint
Quick and easy decoy set-up
Includes 6 feeder decoys
Avian-X AXP Series Painted Honker Walker Decoys, 6-pack
Custom-style painted full body Canada geese decoys
Realistic paint attracts geese
Durable adhesion for a lasting look
Includes 6 walker decoys
GHG Life-Size Pintail Decoys
True detail, precise anatomy, and ultimate realism
The perfect addition to your waterfowl spread
60/40 Dura-Keel for perfect weight distribution
Package includes 8 drakes and 4 hens
Higdon Standard Goose Half Shell, Canada, 6 Pack
Awesome feather detail
Unmatched portability and realism.
21" breast to tail
11" wide
Rig'Em Right XL-6 Slotted Goose Decoy Bag
Holds 6 large fully-body goose decoys
6 slots for individual protection
Fits decoys with bases attached
Two-man carrying handles for mobility
Padded strap and sides for comfort
Flambeau Storm Front Premium Mallard Decoys, 6-pack
Innovative new keel design
UVision coating matches reflective feathers
4 tie-off points and depth adjusting eyelet
4 drakes and 2 hens
Dakota Decoys Floating Canada Goose Decoys, 6-Pack
Durable polyethylene body
Carved and air brushed for added realism
Bottom receses keep decoy in place
Heavy weighted keel automatically rights itself
Molded cleat for tying at varying depths
Hard Core Standard Mallard Floating Decoys, 6-Pack
Amazingly lifelike design
12 different paint templates for added realism
Postures designed with a complete spread in mind
WhaleTail keel creates realistic movement
Rig'Em Right 6-Slotted Floater Goose Decoy Bag
Holds 6 floater goose decoys with heads attached
6 slots for individual protection
Bottom drains for maximum flotation
Cushioned side-panel for comfort
Padded adjustable shoulder straps
GHG Pro-Grade Series Decoys, Blue-Winged Teal, 6-Pack
Multiple head options
Exceptional detail
New! MOJO Booty Shaker Mallard Motion Decoy
Makes th MOJO Mallard create ripples splashes
Simply position the paddle in the water
The decoys natural motion creates ripples
New! MOJO Blue Wing Teal Motion Decoy
Realistic body with superfast wings
MOJOs patented direct drive system
Includes 3-piece pole ideal for puddles
Operates up to 16 hours on 4 AA batteries
New! MOJO Swimmer Mallard Motion Decoy
Jet pumps move decoy without clogging
Cycling setting moves decoy intermittently
Creates a realistic "V"-shaped wake
Runs up to 8 hours on a charged battery
New! MOJO Mama Jama Sound & Splash Decoy
Spinning wing decoy with natural sounds
Produces ripples and moving water sounds
Features mallard hen body with floating base
Controlled by a rechargeable 12V battery


text:
Low Flat-Rate Shipping; Free on Orders Over $75 / 365-Day Returns and Free Return Shipping on All Skates
Free Shipping!
Lowest Price Guarantee
The Warrior Swagger Goal Stick features a glass laminated birch and aspen core handle that runs completely through the paddle for strength.
The Swagger goal stick is made with Warrior's Secret Formula Urethane RIM-molded paddle offering the best in impact absorption, durability and vibration dampening. New improved chemical bonding for superior lamination adherence covering the Carbon Composite Deluxe external paddle and blade. All new Platform Heel high-impact ABS insert covers the blade and heel for increased durability on the playing surface and from puck impact. Reinforcing the blade is a Landing Strip, also increasing impact strength and stability. The Swagger is made in the majestic forests of Finland.
- Model Year: 2012
- Model Number: SW2353
- Heritage: Warrior Swagger
- Level of Player: (Intermediate)
- Roller: Up to Professional
- Ice: Up to Advanced
- Sizing Guidelines:
- Regular = Stick used in the Right hand
- Full Right = Stick used in the Left hand
Warrior Hockey Goalie Wood Sticks Intermediate
IW Hockey offers various Intermediate Warrior wood and foam core goalie sticks to choose from including Warrior Swagger, Warrior Abyss, Warrior Woodrow and Warrior Clutch goal sticks. Wood and foam core goalie sticks tend to be slightly heavier then composite sticks but offer increased durability, improved shot dampening, traditional feel and are generally less expensive than composite goalie sticks. For more information check out the IW Hockey learning center page on how to Select and Size a goalie stick.


text:
Nicolette McNair earns conference honor
Stanford second at Pac-12 Championships Session I
Stanford heads to Pac-12 Championships
Cardinal in Session I of Pac-12 Championships
Find out what Nicole has been up to since graduation
Junior named Pac-12 Gymnast of the Week
Freshman shines in defeat at No. 4 Alabama
Stanford travels to No. 4 Alabama
Elizabeth Price wins 2014 AT&T American Cup
Stanford earns 32nd consecutive win over California
SWG seniors reflect on past four years
Stanford plays host to No. 19 California Monday


text:
Up to 70% off
Find out more
Claim a free accessory kit worth £100 Click here for full information and to download the redemption form.Promotion valid between 27 th March 2014 and 30 th June 2014. See terms and conditions for details.*While stocks lastThis multifunctional processor comes with a range of attachments to allow you to complete all the tasks in the kitchen. Perfect for juicing soft fruits and cooked vegetables; mash & puree kit for purees and baby food and Dough bowl for mixing and cooking bread. The lid has an extra wide feed tube for slicing / grating and shredding larger pieces of food for more convenience. 1100W commercial grade induction motor.
Buy & Collect - FREE (7 days a week)
Order before 10pm for collection instore from 12 noon the NEXT DAY or on a day of your choice
(For Belfast and Dundrum please allow up to 72hrs for delivery. Our City store is closed on Sunday.)
Standard - £3 (Monday to Friday)
FREE on orders of £50 or more. Delivery within 3 - 5 working days.
Next Day - £6 (Monday to Saturday)
Order before 7pm for delivery the NEXT DAY
(For Belfast and Dundrum please allow 48hrs for delivery. Our City and Cirencester stores are closed on Sunday.)
Next Evening - £6 (Monday to Sunday 6-10pm)
Selected postcodes only. Order before Midnight for delivery the following evening
Nominated Day - £6 (Monday to Saturday)
Same Day - £6 (Monday to Friday)
Selected postcodes only. Order by 12noon for delivery between 6-9pm.
Ireland - £3
FREE on orders of £50 or more*. Delivery within 3 - 5 working days.
Find out more about delivery and charges
We hope you will love your new things but if you don't, you are welcome to return your items free of charge. Here's how to do it:
To a Store
Bring your items and proof of purchase into store within 14 days from the day your parcel arrives, for a full refund via the original payment method. Or within 28 days, when you can either exchange your items or take a Gift Card to the value of your items.
By Post
Please send your return by post or courier within 14 days from the day your parcel arrives for a full refund via the original payment method. Or within 28 days, when we will refund you with an eVoucher to the value of your items.
Paypal Refunds
You will need to return your goods by post, if PayPal was your original payment method and you would like the refund back to your account. If you make your return to a store, we will only able to give you a House of Fraser gift card to the same value.
See the full refund policy
Required information
Product code: 173907565
Please select a location
Copyright © 1999 - 2014 House Of Fraser (Stores) Ltd